Picture of Connect Biopharma Holdings logo

CNTB Connect Biopharma Holdings Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Annual cashflow statement for Connect Biopharma Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSPROSPECTUS20-F
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
Net Income/Starting Line-93.9-169-779-1,305
Depreciation
Amortisation
Non-Cash Items30.361.2613735
Unusual Items
Other Non-Cash Items
Changes in Working Capital-6.0716.4-2.8520.8
Change in Accounts Receivable
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Cash from Operating Activities-69-90.3-167-545
Capital Expenditures-1.19-1.07-15.3-25.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items59.3-2.2718.2-8.78
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities58.1-3.342.93-34
Financing Cash Flow Items-9.860-3.95-111
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities369-0.3969191,316
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash361-92.6701697

Or unlock with your email

Or unlock with your email